Literature DB >> 6032054

Drug urinary excretion data--some aspects concerning the interpretation.

B K Martin.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 6032054      PMCID： PMC1557205          DOI： 10.1111/j.1476-5381.1967.tb01951.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  11 in total

1.  SOME POSSIBLE ERRORS IN THE PLOTTING AND INTERPRETATION OF SEMILOGARITHMIC PLOTS OF BLOOD LEVEL AND URINARY EXCRETION DATA.

Authors:  J G WAGNER
Journal:  J Pharm Sci       Date:  1963-11       Impact factor: 3.534

2.  Direct proportionality of urinary excretion rate and serum level of tetracycline in human subjects.

Authors:  T CHULSKI; R H JOHNSON; C A SCHLAGEL; J G WAGNER
Journal:  Nature       Date:  1963-05-04       Impact factor: 49.962

3.  Excretion equations and interpretation for digitoxin.

Authors:  J HOUGH; J V SWINTOSKY
Journal:  Nature       Date:  1957-01-12       Impact factor: 49.962

4.  Sulfaethylthiadiazole. II. Distribution and disappearance from the tissues following intravenous injection.

Authors:  J V SWINTOSKY; M J ROBINSON; E L FOLTZ
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1957-07

5.  Sulfaethylthiadiazole. III. Kinetics of absorption, distribution and excretion.

Authors:  J V SWINTOSKY; E L FOLTZ; A BONDI; M J ROBINSON
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1958-02

6.  Kinetic studies of the metabolism of foreign organic compounds; the formation of benzoic acid from benzamide toluene, benzyl alcohol and benzaldehyde and its conjugation with glycine and glucuronic acid in the rabbit.

Authors:  H G BRAY; W V THORPE; K WHITE
Journal:  Biochem J       Date:  1951-01       Impact factor: 3.857

7.  Absorption, distribution and excretion of amantadine hydrochloride.

Authors:  W E Bleidner; J B Harmon; W E Hewes; T E Lynes; E C Hermann
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

8.  Kinetics of elimination of drugs possessing high affinity for the plasma proteins.

Authors:  B K Martin
Journal:  Nature       Date:  1965-08-28       Impact factor: 49.962

9.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02

10.  A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man.

Authors:  A J Cummings; M L King; B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02
View more
  14 in total

1.  Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Authors:  H Boxenbaum
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 2.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

3.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

4.  Pharmacokinetics of pindolol in man.

Authors:  R Gugler; W Herold; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.

Authors:  H W Devonshire; I Kong; M Cooper; T P Sloan; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

6.  Pharmacokinetics of high-dose methotrexate in dogs. An experimental model with diffusion chambers.

Authors:  P Porpaczy; C P Schmidbauer; A Georgopoulos; A T Endler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Elimination kinetics of thiopentone in mothers and their newborn infants.

Authors:  F Gaspari; G Marraro; G F Penna; R Valsecchi; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 8.  Measurement of the renal clearance of drugs.

Authors:  G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

9.  Measurement of antipyrine half-life from urinary drug concentrations.

Authors:  G Taylor; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

10.  Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man.

Authors:  R Testa; R Latini
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.